FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2097372908> ?p ?o ?g. }

• W2097372908 endingPage "1382" @default.
• W2097372908 startingPage "1374" @default.
• W2097372908 abstract "Abstract In contrast to the overwhelming success of radiolabeled antibodies in treating hematologic malignancies, only modest success has been achieved in the radioimmunotherapy of solid tumors. One of the major limitations in successful application of radioimmunotherapy is the large molecular size of the intact immunoglobulin that results in prolonged serum half-life and poor tumor penetration and uptake. With the advent of antibody engineering, small molecular weight antibody fragments exhibiting improved pharmacokinetics and tumor penetration have been generated. However, their clinical application has been limited by suboptimal tumor uptake and short tumor residence time. There is a greater realization that optimization of the molecular size of the antibodies alone is not sufficient for clinical success of radioimmunotherapy. In addition to their size, radiolabeled antibodies encounter other impediments before reaching their target antigens expressed on the cell surface of solid tumors. Some of the barriers include poor blood flow in large tumors, permeability of vascular endothelium, elevated interstitial fluid pressure of tumor stroma, and heterogeneous antigen expression. Recent research has considerably improved our understanding and appreciation of these forces, and the new wave of optimization strategies involves the use of biological modifiers to modulate the impediments posed by solid tumors. In combination with radiolabeled antibodies, various agents are being used to improve the tumor blood flow, enhance vascular permeability, lower tumor interstitial fluid pressure by modulating stromal cells and extracellular matrix components, up-regulate the expression of target antigens, and improve the penetration and retention of the radiopharmaceuticals. This review outlines ongoing research efforts involving biological modifiers to optimize the uptake and efficacy of radiolabeled antibodies for the treatment of solid tumors." @default.
• W2097372908 created "2016-06-24" @default.
• W2097372908 creator A5037944535 @default.
• W2097372908 creator A5085256777 @default.
• W2097372908 creator A5090154787 @default.
• W2097372908 date "2007-03-01" @default.
• W2097372908 modified "2023-10-16" @default.
• W2097372908 title "Optimization of Radioimmunotherapy of Solid Tumors: Biological Impediments and Their Modulation" @default.
• W2097372908 cites W1573363574 @default.
• W2097372908 cites W1582946240 @default.
• W2097372908 cites W1604064808 @default.
• W2097372908 cites W1966523502 @default.
• W2097372908 cites W1966755566 @default.
• W2097372908 cites W1967907548 @default.
• W2097372908 cites W1969054117 @default.
• W2097372908 cites W1969464944 @default.
• W2097372908 cites W1972609102 @default.
• W2097372908 cites W1975604213 @default.
• W2097372908 cites W1977887541 @default.
• W2097372908 cites W1979249150 @default.
• W2097372908 cites W1983257260 @default.
• W2097372908 cites W1986810252 @default.
• W2097372908 cites W1987501782 @default.
• W2097372908 cites W1993866602 @default.
• W2097372908 cites W1994342180 @default.
• W2097372908 cites W1998367545 @default.
• W2097372908 cites W2002268410 @default.
• W2097372908 cites W2006013401 @default.
• W2097372908 cites W2006202974 @default.
• W2097372908 cites W2008119533 @default.
• W2097372908 cites W2012988607 @default.
• W2097372908 cites W2014973157 @default.
• W2097372908 cites W2017144261 @default.
• W2097372908 cites W2019270411 @default.
• W2097372908 cites W2021396643 @default.
• W2097372908 cites W2027292955 @default.
• W2097372908 cites W2041869928 @default.
• W2097372908 cites W2043303586 @default.
• W2097372908 cites W2043639052 @default.
• W2097372908 cites W2044817251 @default.
• W2097372908 cites W2049298293 @default.
• W2097372908 cites W2049761924 @default.
• W2097372908 cites W2050821833 @default.
• W2097372908 cites W2054282056 @default.
• W2097372908 cites W2055225894 @default.
• W2097372908 cites W2057513699 @default.
• W2097372908 cites W2069151606 @default.
• W2097372908 cites W2069802714 @default.
• W2097372908 cites W2082099286 @default.
• W2097372908 cites W2083437069 @default.
• W2097372908 cites W2083982805 @default.
• W2097372908 cites W2086073957 @default.
• W2097372908 cites W2090591117 @default.
• W2097372908 cites W2091064244 @default.
• W2097372908 cites W2095153351 @default.
• W2097372908 cites W2097091783 @default.
• W2097372908 cites W2100677474 @default.
• W2097372908 cites W2106456486 @default.
• W2097372908 cites W2106946113 @default.
• W2097372908 cites W2109952783 @default.
• W2097372908 cites W2117243396 @default.
• W2097372908 cites W2117388663 @default.
• W2097372908 cites W2124595784 @default.
• W2097372908 cites W2129003421 @default.
• W2097372908 cites W2136367991 @default.
• W2097372908 cites W2136917811 @default.
• W2097372908 cites W2145312678 @default.
• W2097372908 cites W2148985327 @default.
• W2097372908 cites W2161825162 @default.
• W2097372908 cites W2166634853 @default.
• W2097372908 cites W2171041415 @default.
• W2097372908 cites W2172298636 @default.
• W2097372908 cites W2275253339 @default.
• W2097372908 cites W2338107399 @default.
• W2097372908 cites W4233232262 @default.
• W2097372908 cites W4250351113 @default.
• W2097372908 cites W4253930672 @default.
• W2097372908 doi "https://doi.org/10.1158/1078-0432.ccr-06-2436" @default.
• W2097372908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17309914" @default.
• W2097372908 hasPublicationYear "2007" @default.
• W2097372908 type Work @default.
• W2097372908 sameAs 2097372908 @default.
• W2097372908 citedByCount "86" @default.
• W2097372908 countsByYear W20973729082012 @default.
• W2097372908 countsByYear W20973729082013 @default.
• W2097372908 countsByYear W20973729082014 @default.
• W2097372908 countsByYear W20973729082015 @default.
• W2097372908 countsByYear W20973729082016 @default.
• W2097372908 countsByYear W20973729082017 @default.
• W2097372908 countsByYear W20973729082018 @default.
• W2097372908 countsByYear W20973729082019 @default.
• W2097372908 countsByYear W20973729082020 @default.
• W2097372908 countsByYear W20973729082021 @default.
• W2097372908 countsByYear W20973729082022 @default.
• W2097372908 countsByYear W20973729082023 @default.
• W2097372908 crossrefType "journal-article" @default.
• W2097372908 hasAuthorship W2097372908A5037944535 @default.
• W2097372908 hasAuthorship W2097372908A5085256777 @default.

• next